# Servier’s $1.5B bet on Edgewise drug fails five months in

> **Open Intelligence Dossier** · First detected: 2026-11-04 14:40 UTC · Category: Business

## Executive Summary
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
&quot;Servier’s $1.5B bet on Edgewise drug fails five months in&quot; is generating significant coverage in the Business category, with 7 articles from 7 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Fierce Biotech, European Biotechnology Magazine, The Pharma Letter and Muscular Dystrophy Association. PULSE measures a story&#039;s velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE&#039;s extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Fierce Biotech | Servier’s $1.6B muscular dystrophy bet on Edgewise delivers quick-fire pivotal failure | [Source Link](https://news.google.com/rss/articles/CBMirwFBVV95cUxQUExBNEI2M3BLeTVlSHFSQS00WG85dzJ3ZlpXemlqczNiX3B6X3lXTjU3Y2htM2s2WWxpZlN3MnZfSEJUVFU1RE5ueW1ELWRadk1uN0VDX20xeG1TakJIUGdYLVEtUzhIenBLME5wRURNZkw4cEJEcXFiN0UtdVpDcjdRWVQ5bngwRExnT29YSTNCR2ZrNktGcUNfaXJnVm9wX1ozV3lIRjZLdElTSmN3?oc=5) |
| European Biotechnology Magazine | Servier’s $1.55B Edgewise acquisition backfires after Phase 3 setback | [Source Link](https://news.google.com/rss/articles/CBMitgFBVV95cUxNR2lzN09ZdkNjeHFFeFZpNXVacHd2emJMU3lCakJheVlGb3FncVdDaDY5TjRFUlc1TmY1Z09oWm9iaWdJZEI2bnRxWGNtS0QxdHhYbEdmcGNUWm5MUzRzajlkV2lmRUdOZ2RaZE5ocXVlbjVqd2Qxc0ZibHFoSzcyYzFGclpJZmtSODNJVjM4d1hLUzJoa0FfR0dMXzczRkFMSlRvSUc5NjhIQVgxNVpHem9JeEtqZw?oc=5) |
| The Pharma Letter | Servier’s sevasemten misses muscular dystrophy endpoints | [Source Link](https://news.google.com/rss/articles/CBMitAFBVV95cUxQdlJMWXNab2hobGQyNFBNeURtOVBOSTFHbm5FdDVJWTdjQXVyZWhPTW45c05vTHpKV25xWlItTUpNV0E2UU1kZ212OXhoVVhiMUp1bnd3UzdtRVR2THNIeHlPS3NBM2VMLUNCWlBRcnRCcHlwQ0lWcFQ5dllFbG80RFRTTC1Iay1sQVEwTVZUd2ZUTm9VWFRxYTV2cTNKMkd2MXR6Qmw1YUFraUhRVnF5UEZwelI?oc=5) |
| Muscular Dystrophy Association | Statement from the Muscular Dystrophy Association on Servier’s Announcement of Topline Results in Becker Muscular Dystrophy Study | [Source Link](https://news.google.com/rss/articles/CBMi1wFBVV95cUxONHBxV1gwQVA2bHhPQktMZzI5b2ZGZnc1Q0Q1Wm40cXdKMHQ1UHdSMXhkcWwzQVNGRk4zMlZLOHZyWk9JY2hKLUlvU3U1ZGEyblhfdDhjcE4wSmN2dy1HcEF4a0NPRVNRMTJIc1I3UWpXOENNbk1CYjdJakdSOFZxdy02OEZPeEdGZVBXTFpyWXhXdXBFdVVaYkhGTlNmUGo3WUVJc3I0S0VHUE8tX1QwLUZiRDNXTndxWUI5eEpWTEdWMGlFbFNHXzVENmRrVjZ5amc0bE1sSQ?oc=5) |
| STAT | Servier’s $1.55 billion muscular dystrophy drug fails first major test | [Source Link](https://news.google.com/rss/articles/CBMimwFBVV95cUxQbFozdHJXUG5zT0ptR01VQ2V4VWpzZ0dZTzhxWjR0TlQyb1NjanQ4NmE5ZENOTUZkZ3FLSHBhUmFmb2YwSEtGY0h1WElTTDQ5eU5iSDJQYXJCdm9QQjlkT2NHRGE2OTZVdkt5MDJTdl9aZWUzVG45LXZhSjdwbGNaRnZwSWF1V0tPaWdqcUlCXzhVWnFwbGpmSU1vbw?oc=5) |
| Servier | Servier Announces Topline Pivotal Results for Sevasemten in Becker Muscular Dystrophy | [Source Link](https://news.google.com/rss/articles/CBMif0FVX3lxTE9OSF9GNG1lYnQ4VmZiamhjdjZfaUxyWno3dzNYTHlqMWduNWJXN0pwa3luNF9UQnFvRHFIS0JwRl9lblJBSEg4Z2gyWjYxOEs3QmJ5MkJNNTNXNktXa1ZaNXFEQWtUMGJLdzQ4VFdLQXEydi1xRy0yYkVVemtSY2s?oc=5) |
| Endpoints News | Servier’s $1.5B bet on Edgewise drug fails five months in | [Source Link](https://news.google.com/rss/articles/CBMihgFBVV95cUxNWlFGUTYwSVowOVJZMGNfeXhFR2pqMEZXZm15LXBOdFZzYlZzaEhhT2lSSE1zRWhBZG1YV05xTEpkRGRCUFN2RzZMcnFreDlvdGNzM0lWb19JUENsZHZORVJIOTZiZ1hWYmwyeDBzeV9uR1RzRjdfVUdsRno1bmQ1ZTRHTG0tUQ?oc=5) |

---
*Canonical Source: https://pulse.byoaiapps.com/trend/2026-11-04/servier-s-1-5b-bet-on-edgewise-drug-fails-five-months-in*
